Sudeep Pharma · NSE: SUDEEPPHRM · BSE: 544619

Q3 FY26 results · Oct–Dec 2025

Sudeep Pharma reported revenue from operations of ₹172.34 crore and net profit of ₹47.70 crore for Q3 FY26 (Oct–Dec 2025), on a consolidated basis.

Consolidated · ₹ crore
Item	Q3 FY26	Q3 FY25	YoY	Q2 FY26	QoQ
Revenue from operations	172.34	—	—	162.67	+5.9%
Other income	6.84	—	—	10.17	−32.7%
Total income	179.17	—	—	172.83	+3.7%
Profit before tax	61.78	—	—	59.53	+3.8%
Net profit for the period	47.70	—	—	46.78	+2.0%
Attributable to shareholders of the company	(2.03)	—	—	45.75	Turned loss
EPS, basic (₹)	4.29	—	—	4.20	not comparable
Net margin (%)	27.7	—		28.8

Standalone · ₹ crore
Item	Q3 FY26	Q3 FY25	YoY	Q2 FY26	QoQ
Revenue from operations	90.28	—	—	87.88	+2.7%
Other income	9.44	—	—	12.83	−26.4%
Total income	99.72	—	—	100.71	−1.0%
Profit before tax	36.62	—	—	39.90	−8.2%
Net profit for the period	26.87	—	—	29.74	−9.7%
EPS, basic (₹)	2.42	—	—	2.67	not comparable
Net margin (%)	29.8	—		33.8

Consolidated

Standalone